ResearchMoz

Innovation in the Prefilled Syringe Market - Biologics and Autoinjection Devices Shaping Future R&D Trends

GBI Research
Published Date » 2012-12-14
No. Of Pages » 28

Innovation in the Prefilled Syringe Market Biologics and Autoinjection Devices Shaping Future R&D Trends

Summary

GBI Research, the leading business intelligence provider, has released its latest research, Innovation in the Prefilled Syringe Market Biologics and Autoinjection Devices Shaping Future R&D Trends, which provides insights into possible future avenues of R&D in the prefilled syringe market. This includes an overview of problems and possible solutions, as well as discussion of how the devices have developed to date to address problems with contamination, safety, fragility and ease of use.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

The market for prefilled syringes is being driven by the rise in popularity of autoinjection devices for the home-use market. As health authorities seek to reduce costs, facilitating patients in self-administering their medication is one major way of reducing the strain on resources for providers. Additionally, patients prefer this option as it does not require them to travel to hospital and can be accommodated in their own home.

Innovation is also being driven by safety. This area has seen increasing innovation in response to regulations and guidelines concerning needlestick injury. This is an area of rising concern as the number of logged needlestick injuries in healthcare workers is high and thought to be considerably under-reported. Measures to ensure healthcare provider safety have been put in place, and pharmaceutical companies are responding by improving the safety of their prefilled syringes in order to increase their appeal and gain market share. Safety devices have moved from active devices, which require activation by the user, to passive, which are automatically activated. The next steps are being made in integrating the safety device into the needle during manufacture.

The development of injectable biologic therapies is a major factor in the future prospects of prefilled syringes. Although oral biologics are something that companies are aiming for and there are some in development, many peptides are broken down too quickly in the stomach and are therefore not useful in treatment. The mainstay of biologic treatment is likely to remain injectable, whether intravenous, subcutaneous or intramuscular, for the foreseeable future. As such, companies need to overcome the limitations of prefilled syringes in order to provide convenient method of administration and win market share.

Scope

  • An overview of issues in the market.
  • Innovative solutions to these problems.
  • Future developments expected in the market by leading players

Reasons to buy

  • Understand how the prefilled syringe market has adapted to issues.
  • Predict which innovations are likely to be most successful in the future.
  • Gain an understanding of areas of unmet need in the market
Table of Contents

1 Table of Contents
1 Table of Contents 4
1.1 List of Figures 5

2 Innovation in Prefilled Syringes - Overview 6
2.1 Overview 6

3 Innovation in Prefilled Syringes - Introduction 7
3.1 What are Prefilled Syringes? 7
3.2 The Current Position of Prefilled Syringes in the Pharmaceutical Market 7
3.3 Factors Fueling Growth of Prefilled Syringes 7
3.4 Issues around the Use of Prefilled Syringes 8
3.5 Where Does Innovation Lie? 8

4 Innovation in Prefilled Syringes - Current Device Technologies and Associated Drivers and Barriers 9
4.1 Glass Syringes versus Plastic Syringes 9
4.1.1 Fragility 9
4.1.2 Dimensional Variability 9
4.1.3 Siliconization 9
4.1.4 Delamination 10
4.1.5 Tungsten Contamination 10
4.2 Autoinjection Devices 11
4.3 Safety Devices on Prefilled Syringes 11
4.4 Prefilled Diluent Syringes 12
4.5 Biologics Driving Innovation in Prefilled Syringes 12

5 Innovation in Prefilled Syringes - Formulation Considerations and Challenges for Pharmaceutical Companies 13
5.1 Drug Viscosity 13
5.2 Extractables and Leachables 13
5.3 Lyophilized Drugs versus Liquid-stable Formulations 14

6 Innovations in Prefilled Syringes - Overcoming Current Barriers and Trends in Development 15
6.1 Innovative Ways of Gaining Life Cycle Extensions for Existing Products 15
6.2 Plastic Syringes Offer Some Improvements over Traditional Glass Syringes 16
6.2.1 Polypropylene 16
6.2.2 Cyclo-olefin Polymers and Co-polymers 16
6.3 Extractables and Leachables 18
6.3.1 Glass Coatings - Reducing Silicone and Silicone Baking 18
6.3.2 Coated Stoppers 18
6.4 Safety Innovations 19
6.5 Integrated Needles - Advancements on the Luer Lock System 20
6.6 Filling Technologies and Removing the Air Bubble 20
6.7 Needle Length - Reducing Length can Increase Accuracy of Subcutaneous Injections 20
6.8 Manufacturing Advances - Sterilizing Syringes 21
6.8.1 Restricted Access Barrier Systems 21
6.8.2 Electron Beam Sterilization Tunnels 21
6.9 Automating and Streamlining the Manufacture of Prefilled Syringes 22
6.10 Manufacturing Flexibility and Integrated Systems 22
6.11 Testing of Prefilled Syringes 23
6.12 Customization of Prefilled Syringes 23
6.13 Self-injection Improvements 24
6.14 Patient-centric Focus for CMOs 24

7 Appendix 25
7.1 Market Definitions 25
7.2 Abbreviations 25
7.3 Bibliography 25
7.4 Research Methodology 26
7.4.1 Coverage 26
7.4.2 Secondary Research 27
7.4.3 Primary Research 27
7.4.4 Expert Panel Validation 27
7.5 Contact Us 28
7.6 Disclaimer 28

List of Tables

NA

List of Figures


Figure 1: Innovation of a Drug Product to Improve Market Differentiation, Prefilled Syringes, 2012 15

Upcoming Reports:

Nanomaterials in Theranostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Theranostics refer to a combination of diagnosis and therapy. Diagnosis includes specific tests for a patient to detect a possible disease whereas therapy includes treatment for the diagnosed disease. Theranostics forms a key part of personalized medicine. Nanomaterials can be incorporated and utilized for performing dual functions of diagnostics and therapeutics i.e. Theranostics. . Nanomaterials play a very crucial part in the theranostics. The nanomaterials utilized in theranostics are microfluidic and biochips, nano-analytical probes, molecular medicines and...
Pneumonia Drugs & Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Pneumonia is a common lung infection caused by a variety of microorganisms such as bacteria, virus, fungi and parasites. In pneumonia the air sacs of lungs that are known as alveoli are filled with fluid or pus causing inflammation. The common symptoms of pneumonia are cough with phlegm, sneezing, sore throat, chills, fever and trouble in breathing. Pneumonia is usually a mild disease but under certain situations can be lethal. Children, elderly people and those with recent viral infections, lung disease and heart disease are at higher risk of developing pneumonia compared to...
Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
The generic drugs industry comprises of the manufacture and marketing of certain drugs which have the same active ingredients as the brand-name drugs manufactured by any pharmaceutical company. The major benefit of generic drugs is that the cost of such drugs is much less than that of branded drugs. Generic drugs come under the same governing framework as that of the brand-name drugs. The rationale behind generic drugs is that the patented drugs generally have a patent life of 20 years. However, the patent life of such drugs begins from the clinical trials and thus their commercial...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Microsoft to Complete Nokia Purchase by April 25
Apr 23, 2014  
The Microsoft-Nokia deal that made headlines when it was announced is finally on its way to being completed. This proves that even the most complex deals do culminate with time. This week, Microsoft announced that it would complete the purchase of a major part of Nokia’s hardware assets by Friday. The much discussed deal-though on the brink of completion-has witnessed some adjustments...
Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...